Q3 2025 Earnings Call October 24, 2025 8:30 AM EDTCompany ParticipantsThomas Larsen - Head of Investor RelationsPaul Hudson - CEO ...
Guselkumab offers the flexibility of self-administration from the start of treatment in both ulcerative colitis (UC) and Crohn’s disease (CD),1,2,3 providing the simplicity of a fully subcutaneous ...
You will hear more from Sam and Mark on those results in a moment. It is exactly these sorts of financial results that gave ...
C.H. Robinson is an $18 billion link in the global supply chain — the largest truckload broker in North America. Under Dave ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback